| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Andrea Zangrando
|
|||||||
| GSE7757 |
Robustness of gene expression signatures in leukemia: comparison of three distinct total RNA preparation procedures.
|
99 |
|
Andrea Zangrando | May 31, 2007 | |||
| GSE10792 |
Genome wide genotyping and gene expression data of childhood B-cell precursor ALL without known genetic aberrations
|
160 | Andrea Zangrando | Apr 25, 2008 | ||||
| GSE14062 |
MLL rearrangements in pediatric ALL and AML: MLL specific and lineage specific signatures
|
140 | Andrea Zangrando | Jul 22, 2009 | ||||
| GSE14858 |
Gene exprssion profile classification predicts clinical outcome in juvenile myelomonocytic leukemia
|
40 | Andrea Zangrando | Jan 01, 2010 | ||||
| GSE13576 |
Early Relapse in ALL is identified by Time To Leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways
|
209 |
|
Andrea Zangrando | Feb 10, 2011 | |||
| GSE19577 |
MLL partner genes confer distinct biological and clinical signatures of pediatric AML, an AIEOP study
|
42 |
|
Andrea Zangrando | Apr 21, 2011 | |||
| GSE42765 |
MLLT10 gene recombinations in pediatric T-Acute Lymphoblastic Leukemia
|
11 | Andrea Zangrando | Jul 03, 2013 | ||||
| GSE39816 |
Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia
|
72 | Andrea Zangrando | Nov 05, 2013 | ||||
| GSE45404 |
Integrative computational biology and molecular determinants of rectal cancer resistance to chemoradiotherapies
|
80 | Andrea Zangrando | Jan 01, 2017 |
